MedTrace Logo

Association of Centre of Excellence Self-Administered Questionnaire (CESAM) Score and Frailty Levels

NCT03962972 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1741

Last updated 2024-04-05

No results posted yet for this study

Summary

This study evaluates the association of the Self-Administered questionnaire (CESAM) score and its stratification of frailty in four levels with incident adverse health events in older community dwellers and to compare this association with three validated frailty indexes which are the Cardiovascular Health Study frailty index, Study of Osteoporotic Fracture index and Rockwood frailty index.

Conditions

Interventions

OTHER

Frailty evaluation

It will be used a questionnaire that is called:The Centre of Excellence Self-Administered questionnaire (CESAM). The score of this questionnaire and its stratification of frailty in four levels with incident adverse health events in older community dwellers will be compare with validated frailty indexes which are the Cardiovascular Health Study frailty index, Study of Osteoporotic Fracture index, Rockwood frailty index, 6-ietm brief geriatric assessment (BGA), "Program of Research on the Integration of Services for the Maintenance of Autonomy" (PRISMA-7) and b) two other frailty index developed over the COVID-19 pandemic which are "Évaluation SOcio-GÉriatrique" (ESOGER) and "CriblAge et REcommandations" (CARE).

Sponsors & Collaborators

  • Jewish General Hospital

    lead OTHER

Principal Investigators

  • Olivier Beauchet, MD · Jewish General Hospital

Eligibility

Min Age
67 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-23
Primary Completion
2021-12-15
Completion
2025-01-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03962972 on ClinicalTrials.gov